caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1326071812

Joel TeicherMD

Obstetrics & GynecologyAlbuquerque, NMI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
421
Beneficiaries
—
Total drug cost
$24K
Distinct drugs
14
Brand share
34.0%
Top prescribed drugs
Estradiol162 claims
Estradiol/Norethindrone Acet37 claims
Medroxyprogesterone Acetate24 claims
Estradiol23 claims
Acyclovir22 claims
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 320009
Hospital
CCN 320017
Hospital
REFERRAL NETWORK

Where Joel Teicher's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NPI 13967811341546
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
NPI 13967811341738
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$288
Payment records
13
By payment type
Food and Beverage$288
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
95
Unique beneficiaries
—
Total services
108
Distinct HCPCS
4
Medicare payment
$7K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 121 Obstetrics & Gynecology providers in NM — top quintile (cohort median 63).